Everolimus TFOS is a kinase inhibitor indicated in adult and pediatric patients aged one year and older with tuberous ...
It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback